Aclarion (ACONW) Net Income towards Common Stockholders (2021 - 2026)
Aclarion (ACONW) reported Net Income towards Common Stockholders of -$2.9 million for Q1 2026, down 39.6% on a YoY basis from -$4.7 million in Q1 2025, and down 51.05% quarter-over-quarter from -$1.9 million in Q4 2025.
Aclarion (ACONW) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Aclarion has reported Net Income towards Common Stockholders for 6 years, with the latest figure at -$2.9 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 39.6% year-over-year to -$2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$8.0 million (down 20.19% YoY), and the FY2025 full-year result was -$7.2 million, down 2.66% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$2.9 million, down from -$1.9 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$944610.0 in Q4 2022, with the low at -$3.7 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$1.7 million across 5 years, with a median of -$1.6 million in 2025.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 442.62% — and 2023, when it jumped 60.24%.
- Aclarion's Net Income towards Common Stockholders stood at -$944610.0 in 2022, then slumped by 33.95% to -$1.3 million in 2023, then tumbled by 60.99% to -$2.0 million in 2024, then advanced by 7.26% to -$1.9 million in 2025, then plunged by 51.05% to -$2.9 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$2.9 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 74.33 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 34.01 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 19.11 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | -13.47 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 43.32 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Aclarion | - | - | 3,750.00 | -2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.38 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -998,010.00 |
| Jun 30, 2023 | -1.46 Mn |
| Mar 31, 2023 | -1.18 Mn |
| Dec 31, 2022 | -944,610.00 |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | -3.68 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | -3.24 Mn |
| Jun 30, 2021 | -678,763.00 |